Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-26-077892
Filing Date
2026-06-26
Accepted
2026-06-25 20:15:38
Documents
5
Period of Report
2026-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2618527d2_6k.htm 6-K 22991
2 EXHIBIT 1.1 tm2618527d2_ex1-1.htm EX-1.1 232057
3 EXHIBIT 5.1 tm2618527d2_ex5-1.htm EX-5.1 41834
4 EXHIBIT 10.1 tm2618527d2_ex10-1.htm EX-10.1 205975
5 EXHIBIT 99.1 tm2618527d2_ex99-1.htm EX-99.1 12518
  Complete submission text file 0001104659-26-077892.txt   516544
Mailing Address ZERNIKEDREEF 9 LEIDEN Netherlands
Business Address ZERNIKEDREEF 9 LEIDEN Netherlands 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 261123563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)